The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
The complexity of tau in Alzheimer’s disease
Open accessAbstract
Alzheimer’s disease (AD) is characterized by two major pathological lesions in the brain, amyloid plaques and neurofibrillary tangles (NFTs) composed mainly of amyloid-β (Aβ) peptides and hyperphosphorylated tau, respectively. Although accumulation of toxic Aβ species in the brain has been proposed as one of the important early events in AD, continued lack of success of clinical trials based on Aβ-targeting drugs has triggered the field to seek out alternative disease mechanisms and related therapeutic strategies. One of the new approaches is to uncover novel roles of pathological tau during disease progression. This review will primarily focus on recent advances in understanding the contributions of tau to AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–294 of 294
Boekhoorn, K., Terwel, D., Biemans, B., Borghgraef, P., Wiegert, O., Ramakers, G. J. A., de Vos, K., Krugers, H., Tomiyama, T., Mori, H., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5425-05.2006 · Cited by 166
Secretion of tau via an unconventional non-vesicular mechanism
Merezhko, M., Brunello, C. A., Yan, X., Vihinen, H., Jokitalo, E., Uronen, R.-L., & Huttunen, H. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.078 · Cited by 166
Hatch, R. J., Yan, W., Xia, D., & Götz, J. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1674-1 · Cited by 161
Sohn, P. D., Tracy, T. E., Son, H.-I., Zhou, Y., Leite, R. E. P., Miller, B. L., Seeley, W. W., Grinberg, L. T., & Gan, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0109-0 · Cited by 160
Drubin, D., Kobayashi, S., Kellogg, D., & Kirschner, M. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.5.1583 · Cited by 160
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes
Ait‐Bouziad, N., Lv, G., Mahul‐Mellier, A., Xiao, S., Zorludemir, G., Eliezer, D., Walz, T., & Lashuel, H. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01575-4 · Cited by 160
Snow, A. D., Wight, T. N., Nochlin, D., Koike, Y., Kimata, K., DeArmond, S. J., & Prusiner, S. B. (1990) · PubMed · Cited by 158
Jones, E. M., Dubey, M. K., Camp, P. J., Vernon, B. C., Biernat, J., Mandelkow�, E., Majewski, J. P., & Chi, E. Y. (2012) · Biochemistry · doi:10.1021/bi201857v · Cited by 158
Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons
Brion, J., Octave, J., & Couck, A. M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90533-9 · Cited by 156
Santa‐María, I., Varghese, M., Ksiȩżak-Reding, H., Dzhun, A., Wang, J., & Pasinetti, G. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323279 · Cited by 156
Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia
Seo, J., Kritskiy, O., Watson, L. A., Barker, S. J., Dey, D., Raja, W. K., Lin, Y.-T., Ko, T., Cho, S., Penney, J., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0621-17.2017 · Cited by 156
Neuropil Threads Occur in Dendrites of Tangle—Bearing Nerve Cells
Braak, H., & Braak, E. (1988) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1988.tb00864.x · Cited by 153
Mapping interactions with the chaperone network reveals factors that protect against tau aggregation
Mok, S., Condello, C., Freilich, R., Gillies, A. T., Arhar, T., Oroz, J., Kadavath, H., Julien, O., Assimon, V. A., Rauch, J. N., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0057-1 · Cited by 153
Fischer, D., Mukrasch, M. D., Biernat, J., Bibow, S., Blackledge, M., Griesinger, C., Mandelkow, E., & Zweckstetter, M. (2009) · Biochemistry · doi:10.1021/bi901090m · Cited by 149
Dynamic association of tau with neuronal membranes is regulated by phosphorylation
Pooler, A. M., Usardi, A., Evans, C. J., Philpott, K. L., Noble, W., & Hanger, D. P. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.01.005 · Cited by 148
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease
Zhang, Z., Obianyo, O., Dall, E., Du, Y., Fu, H., Liu, X., Kang, S. S., Song, M., Yu, S.-P., Cabrele, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14740 · Cited by 146
An acetylation–phosphorylation switch that regulates tau aggregation propensity and function
Carlomagno, Y., Chung, D.-E. C., Yue, M., Castanedes-Casey, M., Madden, B. J., Dunmore, J., Tong, J., DeTure, M., Dickson, D. W., Petrucelli, L., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.794602 · Cited by 143 · cited 13×
“Acetylation Tau is a lysine-rich protein, particularly in the region spanning the MBD. Acetylation of tau was first described by Min and colleagues as a novel post-translational modification [119].”
BackgroundInfluentialStancu, I.-C., Vasconcelos, B., Ris, L., Wang, P., Villers, A., Peeraer, E., Buist, A., Terwel, D., Baatsen, P., Oyelami, T., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1413-4 · Cited by 143
Levenga, J., Krishnamurthy, P., Rajamohamedsait, H. B., Wong, H., Franke, T. F., Cain, P., Sigurdsson, E. M., & Hoeffer, C. A. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-34 · Cited by 142
Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion
Ahmed, T., Van der Jeugd, A., Blum, D., Galas, M.-C., D’Hooge, R., Buee, L., & Balschun, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.005 · Cited by 137
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
Van der Jeugd, A., Hochgräfe, K., Ahmed, T., Decker, J. M., Sydow, A., Hofmann, A., Wu, D., Messing, L., Balschun, D., D’Hooge, R., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0987-3 · Cited by 135
Spreading of tau pathology in A lzheimer's disease by cell‐to‐cell transmission
Mohamed, N., Herrou, T., Plouffe, V., Piperno, N., & Leclerc, N. M. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12229 · Cited by 125
Sulfated glycosaminoglycans in amyloid plaques of prion diseases
Snow, A. D., Kisilevsky, R., Willmer, J., Prusiner, S. B., & DeArmond, S. J. (1989) · Acta Neuropathologica · doi:10.1007/bf00687367 · Cited by 124
Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex
Tashiro, K., Hasegawa, M., Ihara, Y., & Iwatsubo, T. (1997) · Neuroreport · doi:10.1097/00001756-199708180-00029 · Cited by 123
Progressive supranuclear palsy : clinical and research approaches
Litvan, I., & Agid, Y. (1992) · Medical Entomology and Zoology · Cited by 122
DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins
Xu, Y., Cui, L., DiBello, A., Wang, L., Lee, J., Saidi, L. F., Lee, J., & Ye, Y. (2018) · Cell Discovery · doi:10.1038/s41421-018-0012-7 · Cited by 122
Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases
Sergeant, N., David, J.-P., Lefranc, D., Vermersch, P., Wattez, A., & Delacourte, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00859-4 · Cited by 117
Selecting a Mouse Model of Alzheimer’s Disease
Chin, J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-744-0_13 · Cited by 115
Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles
Geddes, J. F., Hughes, A. J., Lees, A. J., & Daniel, S. E. (1993) · Brain · doi:10.1093/brain/116.1.281 · Cited by 115
A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy
Trzeciakiewicz, H., Tseng, J., Wander, C. M., Madden, V. J., Tripathy, A., Yuan, C., & Cohen, T. J. (2017) · Scientific Reports · doi:10.1038/srep44102 · Cited by 115
Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue
Kaufman, S. K., Thomas, T. L., Tredici, K. D., Braak, H., & Diamond, M. I. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0442-8 · Cited by 115
Ginsberg, S. D., Che, S., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03641.x · Cited by 111
Wes, P. D., Easton, A. E., Corradi, J., Barten, D. M., Devidze, N., DeCarr, L. B., Truong, A. B., He, A., Barrezueta, N. X., Polson, C. T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106050 · Cited by 110
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits
Velázquez, R., Ferreira, E., Tran, A., Turner, E. C., Belfiore, R., Branca, C., & Oddo, S. (2018) · Aging Cell · doi:10.1111/acel.12775 · Cited by 110
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
Marquié, M., Siao Tick Chong, M., Antón-Fernández, A., Verwer, E. E., Sáez-Calveras, N., Meltzer, A. C., Ramanan, P., Amaral, A. C., Gonzalez, J., Normandin, M. D., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1740-8 · Cited by 109
Lohith, T. G., Bennacef, I., Vandenberghe, R., Vandenbulcke, M., Salinas, C. A., Declercq, R., Reynders, T., Telan-Choing, N. F., Riffel, K., Celen, S., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.208215 · Cited by 107
Rosenmann, H., Grigoriadis, N., Eldar-Levy, H., Avital, A., Rozenstein‐Tsalkovich, L., Touloumi, O., Behar, L., Ben‐Hur, T., Avraham, Y., Berry, E., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.007 · Cited by 104
Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo
Gorsky, M. K., Burnouf, S., Dols, J., Mandelkow�, E., & Partridge, L. (2016) · Scientific Reports · doi:10.1038/srep22685 · Cited by 100
Bellucci, A., Bugiani, O., Ghetti, B. F., & Spillantini, M. G. (2011) · Neurodegenerative Diseases · doi:10.1159/000322228 · Cited by 99
Tau gene expression in rat sensory neurons during development and regeneration
Oblinger, M., Argasinski, A., Wong, J., & Kosik, K. S. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-08-02453.1991 · Cited by 98
Prions and Protein Assemblies that Convey Biological Information in Health and Disease
Sanders, D. W., Kaufman, S. K., Holmes, B. B., & Diamond, M. I. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.026 · Cited by 98
Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions
Strain, J. F., Smith, R. X., Beaumont, H., Roe, C. M., Gordon, B. A., Mishra, S., Adeyemo, B., Christensen, J. J., Su, Y., Morris, J. C., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005864 · Cited by 97
Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules
Brunello, C. A., Yan, X., & Huttunen, H. J. (2016) · Scientific Reports · doi:10.1038/srep30498 · Cited by 94
Gibbons, G. S., Banks, R. A., Kim, B., Changolkar, L., Riddle, D. M., Leight, S. N., Irwin, D. J., Trojanowski, J. Q., & Lee, V. M. Y. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly010 · Cited by 94 · cited 1×
“Tau monoclonal antibodies are capable of distinguishing tau aggregates in AD brains from those in other tauopathies [239].”
ResultThe Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology
Tseng, J.-H., Xie, L., Song, S., Xie, Y., Allen, L., Ajit, D., Hong, J.-S., Chen, X., Meeker, R. B., & Cohen, T. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.082 · Cited by 93
Nagy, Z., Jobst, K. A., Esiri, M. M., Morris, J. H., King, E. M.-F., MacDonald, B., Litchfield, S., Barnetson, L. P. D., & Smith, A. D. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106857 · Cited by 93
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
Shentu, Y.-P., Huo, Y., Feng, X.-L., Gilbert, J., Zhang, Q., Liuyang, Z.-Y., Wang, X.-L., Wang, G., Zhou, H., Wang, X.-C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.009 · Cited by 90
Kim, W., Lee, S., & Hall, G. F. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.042 · Cited by 90
Amyloid proteins : methods and protocols
Sigurdsson, E. M., Calero, M., & Gasset, M. (2005) · Cited by 87
Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading
Kundel, F., Hong, L., Falcon, B., McEwan, W. A., Michaels, T. C. T., Meisl, G., Esteras, N., Abramov, A. Y., Knowles, T. P. J., Goedert, M., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00094 · Cited by 86
Fauquant, C., Redeker, V., Landrieu, I., Wieruszeski, J., Verdegem, D., Laprévôte, O., Lippens, G. M., Gigant, B., & Knossow, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223545 · Cited by 84
Wang, H., Li, Y., Ryder, J. W., Hole, J. T., Ebert, P. J., Airey, D. C., Qian, H.-R., Logsdon, B., Fisher, A., Ahmed, Z., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0296-y · Cited by 83
Self-citationLasagna‐Reeves, C. A., Sengupta, U., Castillo‐Carranza, D. L., Gerson, J. E., Guerrero‐Munoz, M. J., Troncoso, J. C., Jackson, G. R., & Kayed, R. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-56 · Cited by 83
Transcriptional and conformational changes of the tau molecule in Alzheimer's disease
Hyman, B. T., Augustinack, J. C., & Ingelsson, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.015 · Cited by 79 · cited 1×
“No clear pattern has emerged in AD [44,49,51] as vulnerable areas of the brain containing tau tangles show increased 4R tau isoforms in some cases [52,53] and 3R tau in others [44,54].”
BackgroundNoack, M., Leyk, J., & Richter‐Landsberg, C. (2014) · Glia · doi:10.1002/glia.22624 · Cited by 79
Medda, X., Mertens, L., Versweyveld, S., Diels, A., Barnham, L., Bretteville, A., Buist, A., Verheyen, A., Royaux, I. E., Ebneth, A., et al. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116638029 · Cited by 79
Alternative Splicing in Alzheimer’s Disease
Love, J. E., Hayden, E. J., & Rohn, T. T. (2015) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000010 · Cited by 79
Liu, W.-K., Le, T. V., Adamson, J. L., Baker, M., Cookson, N., Hardy, J., Hutton, M. L., Yen, S.-H. C., & Dickson, D. W. (2001) · Annals of Neurology · doi:10.1002/ana.1159 · Cited by 78
Nuclear Magnetic Resonance Analysis of the Acetylation Pattern of the Neuronal Tau Protein
Kamah, A., Huvent, I., Cantrelle, F., Qi, H., Lippens, G. M., Landrieu, I., & Smet‐Nocca, C. (2014) · Biochemistry · doi:10.1021/bi500006v · Cited by 78
Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss
Tracy, T. E., & Gan, L. (2017) · BioEssays · doi:10.1002/bies.201600224 · Cited by 76
Dissociation of Alzheimer type pathology in a disconnected piece of cortex
Duyckaerts, C. J., Uchihara, T., Seilhean, D., He, Y., & Hauw, J. (1997) · Acta Neuropathologica · doi:10.1007/s004010050645 · Cited by 74
Chong, S., Benilova, I., Shaban, H., Strooper, B. D., Devijver, H., Moechars, D., Eberle, W., Bartic, C., LEUVEN, F. V., & Callewaert, G. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.006 · Cited by 74
Extensive p‐Tau Pathology and SDS‐Stable p‐Tau Oligomers in Alzheimer's Cortical Synapses
Henkins, K. M., Sokolow, S., Miller, C. A., Vinters, H. V., Poon, W. W., Cornwell, L. B., Saing, T., & Gylys, K. H. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00598.x · Cited by 72
Formation, release, and internalization of stable tau oligomers in cells
Wegmann, S., Nicholls, S. B., Takeda, S., Fan, Z., & Hyman, B. T. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13866 · Cited by 70
Monte Carlo Simulations of Tau Proteins: Effect of Phosphorylation
Jho, Y., Zhulina, E. B., Kim, M. W., & Pincus, P. A. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.06.056 · Cited by 69
Wang, Z.-H., Liu, P., Liu, X., Manfredsson, F. P., Sandoval, I. M., Yu, S. P., Wang, J., & Ye, K. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.018 · Cited by 69
Audrain, M., Haure-Mirande, J.-V., Wang, M., Kim, S. H., Fanutza, T., Chakrabarty, P., Fraser, P., St George-Hyslop, P. H., Golde, T. E., Blitzer, R. D., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0258-3 · Cited by 68
Ishikawa, A., Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170509 · Cited by 67
Saint‐Aubert, L., Almkvist, O., Chiotis, K., Almeida, R., Wall, A. E., & Nordberg, A. K. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0204-z · Cited by 63
Croft, C. L., Wade, M. A., Kurbatskaya, K., Mastrandreas, P., Hughes, M. M., Phillips, E. C., Pooler, A. M., Perkinton, M. S., Hanger, D. P., & Noble, W. J. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.97 · Cited by 63
Woollacott, I. O. C., Nicholas, J. M., Heslegrave, A., Heller, C., Foiani, M. S., Dick, K. M., Russell, L. L., Paterson, R. W., Keshavan, A., Fox, N. C., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0405-8 · Cited by 62
Lathuilière, A., Valdés, P., Papin, S., Cacquevel, M., Maclachlan, C., Knott, G. W., Muhs, A., Paganetti, P., & Schneider, B. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-13786-2 · Cited by 60
Initiative, T. A. D. N., Zhang, H., Ng, K. P., Therriault, J., Kang, M. S., Pascoal, T. A., Rosa‐Neto, P., & Gauthier, S. G. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0127-7 · Cited by 58
Hanger, D. P., Gibb, G., de Silva, R., Boutajangout, A., Brion, J., Révész, T., Lees, A. J., & Anderton, B. H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03611-6 · Cited by 55
Seidel, D., Krinke, D., Jahnke, H., Hirche, A., Kloß, D., Mack, T. G. A., Striggow, F., & Robitzki, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049150 · Cited by 52
Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA
Yasojima, K., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01486-9 · Cited by 51 · cited 1×
“No clear pattern has emerged in AD [44,49,51] as vulnerable areas of the brain containing tau tangles show increased 4R tau isoforms in some cases [52,53] and 3R tau in others [44,54].”
BackgroundDeletion of endogenous Tau proteins is not detrimental in Drosophila
Burnouf, S., Grönke, S., Augustin, H., Dols, J., Gorsky, M. K., Werner, J. A., Kerr, F., Alic, N., Martinez, P., & Partridge, L. (2016) · Scientific Reports · doi:10.1038/srep23102 · Cited by 50
Lucke Wold, B. (2017) · Journal of Neurology and Neurosurgery · doi:10.19104/jnn.2017.40 · Cited by 50
Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β
Sen, T., Saha, P., & Sen, N. (2018) · Science Signaling · doi:10.1126/scisignal.aao6765 · Cited by 47
FRMD4A–cytohesin signaling modulates the cellular release of tau
Yan, X., Nykänen, N.-P., Brunello, C. A., Haapasalo, A., Hiltunen, M. O., Uronen, R., & Huttunen, H. J. (2016) · Journal of Cell Science · doi:10.1242/jcs.180745 · Cited by 45
No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice
van Hummel, A., Bi, M., Ippati, S., van der Hoven, J., Volkerling, A. M., Lee, W. S., Tan, D. C. S., Bongers, A., Ittner, A., Ke, Y. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163236 · Cited by 45
Quantification of Tau Load Using [18F]AV1451 PET
Golla, S. S. V., Timmers, T., Ossenkoppele, R., Groot, C., Verfaillie, S. C. J., Scheltens, P., van der Flier, W. M., Schwarte, L. A., Mintun, M. A., Devous, M. D., et al. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1080-z · Cited by 45
Further understanding of tau phosphorylation: implications for therapy
Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1000864 · Cited by 41
Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2
Bilousova, T. V., Elias, C. J., Miyoshi, E., Alam, M. P., Zhu, C., Campagna, J. J., Vadivel, K., Jagodzinska, B. M., Gylys, K. H., & John, V. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.209 · Cited by 39
Gorsky, M. K., Burnouf, S., Sofola-Adesakin, O., Dols, J., Augustin, H., Weigelt, C. M., Grönke, S., & Partridge, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-10225-0 · Cited by 37
14-3-3 proteins and protein phosphatases are not reduced in tau-deficient mice
Fujio, K., Sato, M., Uemura, T., Sato, T., Sato-Harada, R., & Harada, A. (2007) · Neuroreport · doi:10.1097/wnr.0b013e32818b2a0b · Cited by 35
Bories, C., Arsenault, D., Lemire, M., Tremblay, C., Koninck, Y. D., & Calon, F. (2017) · Aging · doi:10.18632/aging.101239 · Cited by 25
Yamamori, H., Khatoon, S., Grundke, I., Blennow, K., Ewers, M., Hampel, H. J., & Iqbal, K. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.022 · Cited by 24
Koss, D. J., Drever, B. D., Stoppelkamp, S., Riedel, G., & Platt, B. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1273-9 · Cited by 23
Preparation and Characterization of Tau Oligomer Strains
Sengupta, U., Murillo, M. C., & Kayed, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7816-8_9 · Cited by 22
Alzheimer's Disease and Frontotemporal Dementia
(2010) · Methods in molecular biology · doi:10.1007/978-1-60761-744-0 · Cited by 18
Shigemoto, Y., Sone, D., Imabayashi, E., Maikusa, N., Okamura, N., Furumoto, S., Kudo, Y., Ogawa, M., Takano, H., Yokoi, Y., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00223 · Cited by 18
Yao, Z., Gao, M., & Huang, Y. (2018) · The FASEB Journal · doi:10.1096/fasebj.2018.32.1_supplement.lb34 · Cited by 5
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Ronaldson, P. T., & Davis, T. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20951995 · Cited by 392
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Cordaro, M., Cuzzocrea, S., & Crupi, R. (2020) · Antioxidants · doi:10.3390/antiox9030216 · Cited by 98
Hu, Z., Chen, P.-H., Li, W., Douglas, T., Hines, J., Liu, Y., & Crews, C. M. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11706 · Cited by 98
In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment
Vanhaute, H., Ceccarini, J., Michiels, L., Koole, M., Sunaert, S., Lemmens, R., Triau, E., Emsell, L., Vandenbulcke, M., & Van Laere, K. (2020) · Neurology · doi:10.1212/wnl.0000000000009818 · Cited by 88
Metadata
- Authors
- Naseri, N. N., Wang, H., Guo, J., Sharma, M., & Luo, W.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 705
- Pages
- 183-194
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2941198005
- Cited by
- 373
- References
- 294
- FWCI
- 19.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.